Aspen Aerogels (NYSE:ASPN) Price Target Cut to $16.00 by Analysts at Roth Mkm

Aspen Aerogels (NYSE:ASPN - Free Report) had its price objective decreased by Roth Mkm from $22.00 to $16.00 in a research note published on Friday,Benzinga reports. Roth Mkm currently has a buy rating on the construction company's stock.

Other equities research analysts have also issued research reports about the stock. Barclays dropped their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. Craig Hallum dropped their price target on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research report on Friday. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday. Finally, StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Saturday, February 8th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $24.67.

Aspen Aerogels Stock Down 1.0 %

Shares of NYSE:ASPN traded down $0.09 during trading on Friday, hitting $8.55. The stock had a trading volume of 2,796,169 shares, compared to its average volume of 2,151,431. The company has a market capitalization of $701.12 million, a PE ratio of 855.36 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm's fifty day moving average is $12.06 and its 200 day moving average is $18.36. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors have recently modified their holdings of ASPN. SG Americas Securities LLC bought a new position in Aspen Aerogels during the 3rd quarter valued at about $379,000. nVerses Capital LLC raised its holdings in shares of Aspen Aerogels by 45.0% during the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company's stock valued at $161,000 after purchasing an additional 1,800 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Aspen Aerogels by 415.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 238,884 shares of the construction company's stock valued at $6,615,000 after purchasing an additional 192,520 shares during the period. Precision Wealth Strategies LLC purchased a new stake in Aspen Aerogels in the third quarter worth approximately $348,000. Finally, Dakota Wealth Management bought a new stake in Aspen Aerogels in the 3rd quarter worth approximately $986,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.